C82.66

Clinical Causes: T h e e x a c t c a u s e o f c u t a n e o u s f o l l i c l e c e n t e r l y m p h o m a i s n o t w e l l u n d e r s t o o d . I t i s b e l i e v e d t o r e s u l t f r o m m u t a t i o n s i n l y m p h o c y t e s , a t y p e o f w h i t e b l o o d c e l l i n v o l v e d i n i m m u n e r e s p o n s e s . E n v i r o n m e n t a l f a c t o r s , g e n e t i c p r e d i s p o s i t i o n , a n d i m m u n e s y s t e m d y s r e g u l a t i o n m a y p l a y r o l e s i n i t s d e v e l o p m e n t . T h e d i s e a s e i s n o t c o n t a g i o u s a n d d o e s n o t r e s u l t f r o m i n f e c t i o n s o r e x t e r n a l e x p o s u r e s d i r e c t l y .

Key Symptoms: Slowly enlarging skin nodules or plaques, often skin-colored or erythematous Presence of multiple lesions, sometimes grouped in patches Lesions predominantly located on the face, scalp, or trunk Possible ulceration or surface changes in skin lesions In cases where intrapelvic lymph nodes are involved, symptoms may include abdominal discomfort, swelling, or pelvic pain Rarely, systemic symptoms such as fever, night sweats, and weight loss

Diagnosis Path: Diagnosing cutaneous follicle center lymphoma with intrapelvic lymph node involvement involves a combination of clinical assessment and laboratory tests: - **Skin biopsy**: Examination of skin lesions under microscopy reveals characteristic follicle center lymphoma cells. - **Imaging studies**: PET scans, CT, or MRI to assess the extent of disease, especially in pelvic lymph nodes. - **Lymph node biopsy**: Confirmatory diagnosis by histopathological examination of affected lymph nodes. - **Immunohistochemistry**: Tests to identify specific markers like CD20, BCL6, and others supporting lymphoma diagnosis. - **Blood tests**: Complete blood count (CBC) and other relevant bloodwork to evaluate overall health and detect systemic involvement.

Treatment Protocols: Treatment strategies depend on the extent and location of the disease: - **Radiotherapy**: Targeted radiation may be used for localized skin lesions. - **Chemotherapy**: Regimens like R-CHOP or other chemo protocols are common when lymph nodes are involved. - **Immunotherapy**: Use of monoclonal antibodies such as rituximab to target cancerous B-cells. - **Observation**: In some cases with indolent disease, doctors may recommend a watchful waiting approach. - **Supportive care**: Managing symptoms and maintaining quality of life during treatment. It is important to work closely with oncology specialists to determine the best individualized treatment plan.